Mineralocorticoid receptor antagonist (finerenone)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mineralocorticoid receptor antagonist (finerenone), covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF [Phase 2]